Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993026priorityCriticalpatent/ECSP993026A/en
Publication of ECSP993026ApublicationCriticalpatent/ECSP993026A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe un método para el tratamiento de la disfunción sexual que comprende administrar una cantidad terapéuticamente efectiva de una combinación de fentolamina y apomorfina, como asi también composiciones farmacéuticas y equipos útiles en aquellos métodos.A method of treating sexual dysfunction is described which comprises administering a therapeutically effective amount of a combination of phentolamine and apomorphine, as well as pharmaceutical compositions and kits useful in those methods.
ECSP9930261999-06-171999-06-17
COMBINATION OF FENTOLAMINE AND APOMORPHINE FOR THE TREATMENT OF HUMAN SEXUAL FUNCTION AND DYSFUNCTION
ECSP993026A
(en)
AN AGENT TO TREAT THE DISORDER OF THE FUNCTION OF VISUAL CELLS. THE METHOD OF TREATMENT AND THE USE OF SUCH AGENT FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION
2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK.